About Recursion Pharmaceuticals, Inc. 
Recursion Pharmaceuticals, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 54 Schemes (26.99%)
Foreign Institutions
Held by 149 Foreign Institutions (35.12%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
19 Million
(Quarterly Results - Jun 2025)
Net Profit:
-172 Million
Pharmaceuticals & Biotechnology
USD 2,008 Million (Small Cap)
NA (Loss Making)
NA
0.00%
-0.54
-70.62%
2.18






